Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumors.
about
Temozolomide: a milestone in neuro-oncology and beyond?Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment.Retrospective analysis of safety and feasibility of a 3 days on/11 days off temozolomide dosing regimen in recurrent adult malignant gliomasManagement of glioblastoma.Using different schedules of Temozolomide to treat low grade gliomas: systematic review of their efficacy and toxicity.Additive antiangiogenesis effect of ginsenoside Rg3 with low-dose metronomic temozolomide on rat glioma cells both in vivo and in vitro.
P2860
Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumors.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Dose-dense regimen of temozolo ...... central nervous system tumors.
@ast
Dose-dense regimen of temozolo ...... central nervous system tumors.
@en
type
label
Dose-dense regimen of temozolo ...... central nervous system tumors.
@ast
Dose-dense regimen of temozolo ...... central nervous system tumors.
@en
prefLabel
Dose-dense regimen of temozolo ...... central nervous system tumors.
@ast
Dose-dense regimen of temozolo ...... central nervous system tumors.
@en
P2093
P356
P1433
P1476
Dose-dense regimen of temozolo ...... central nervous system tumors.
@en
P2093
B Abdulkarim
J-P Armand
J-S Guillamo
K Djazouli
P304
P356
10.1093/ANNONC/MDH003
P577
2004-01-01T00:00:00Z